Exact Sciences Stock Market Outlook
| EXAS Stock | USD 103.31 0.07 0.07% |
Slightly above 53% of EXACT Sciences' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding EXACT Sciences suggests that some traders are interested. EXACT Sciences' investing sentiment can be driven by a variety of factors including economic data, EXACT Sciences' earnings reports, geopolitical events, and overall market trends.
Comfort Level 53
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use EXACT Sciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward EXACT Sciences.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding EXACT Sciences is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell EXACT Sciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for EXACT Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute EXACT Sciences Advice
The EXACT recommendation should be used to complement the investment advice compiled from the current analysts' consensus on EXACT Sciences. Macroaxis does not own or have any residual interests in EXACT Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EXACT Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon EXACT Sciences has a Risk Adjusted Performance of 0.1708, Jensen Alpha of 0.7289, Total Risk Alpha of 0.4468, Sortino Ratio of 1.92 and Treynor Ratio of (2.57)Macroaxis provides trade advice on EXACT Sciences to complement and cross-verify current analyst consensus on EXACT Sciences. Our advice engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure EXACT Sciences is not overpriced, please confirm all EXACT Sciences fundamentals, including its shares outstanding, net income, price to earnings to growth, as well as the relationship between the price to book and current ratio . Given that EXACT Sciences has a price to earning of (38.17) X, we urge you to verify EXACT Sciences market performance and probability of bankruptcy to ensure the company can sustain itself for few more years given your latest risk tolerance and investing horizon.
EXACT Sciences Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 3.25 B. Net Loss for the year was (207.95 M) with profit before overhead, payroll, taxes, and interest of 2.26 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 89.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: Is It Time To Reassess Exact Sciences After The US105 Abbott Offer |
EXACT Sciences Returns Distribution Density
The distribution of EXACT Sciences' historical returns is an attempt to chart the uncertainty of EXACT Sciences' future price movements. The chart of the probability distribution of EXACT Sciences daily returns describes the distribution of returns around its average expected value. We use EXACT Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of EXACT Sciences returns is essential to provide solid investment analysis for EXACT Sciences.
| Mean Return | 0.72 | Value At Risk | -0.23 | Potential Upside | 1.38 | Standard Deviation | 3.57 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of EXACT Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
EXACT Stock Institutional Investors
The EXACT Sciences' institutional investors refer to entities that pool money to purchase EXACT Sciences' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Ameriprise Financial Inc | 2025-06-30 | 2.2 M | Goldman Sachs Group Inc | 2025-06-30 | 2.2 M | Millennium Management Llc | 2025-06-30 | 2.2 M | Holocene Advisors, Lp | 2025-06-30 | 2.1 M | William Blair Investment Management, Llc | 2025-06-30 | 2 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.9 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.9 M | Bamco Inc | 2025-06-30 | 1.9 M | Aqr Capital Management Llc | 2025-06-30 | 1.8 M | Fmr Inc | 2025-06-30 | 26.9 M | Capital World Investors | 2025-06-30 | 18.2 M |
EXACT Sciences Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | (1.2B) | (73.0M) | 366.9M | (3.0M) | 349.4M | 366.8M | |
| Free Cash Flow | (238.0M) | (438.0M) | 31.9M | 74.5M | 356.8M | 374.6M | |
| Depreciation | 180.3M | 197.6M | 206.6M | 214.9M | 221.6M | 232.7M | |
| Other Non Cash Items | 202.0M | 33.8M | (76.4M) | 875.8M | 261.7M | 274.8M | |
| Capital Expenditures | 135.8M | 214.5M | 124.2M | 136.0M | 134.7M | 141.4M | |
| Net Income | (595.6M) | (623.5M) | (204.1M) | (1.0B) | (207.9M) | (218.3M) | |
| End Period Cash Flow | 315.8M | 242.8M | 609.7M | 606.6M | 956.0M | 1.0B | |
| Change To Inventory | (9.2M) | (13.2M) | (7.7M) | (34.9M) | (3.8M) | (4.0M) | |
| Investments | (387.8M) | 278.8M | 49.7M | (442.2M) | 376.5M | 395.3M | |
| Dividends Paid | 17.2M | 18.4M | 37.5M | 169.5M | 194.9M | 108.4M | |
| Change To Netincome | 106.5M | 777.6M | 195.3M | 181.3M | 208.5M | 131.1M | |
| Net Borrowings | (23.7M) | 50M | 138.0M | 216.8M | (249.2M) | (236.7M) | |
| Change Receivables | (27.9M) | (100.5M) | 25.2M | 61.1M | 70.3M | 73.8M |
EXACT Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to EXACT Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that EXACT Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a EXACT stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.73 | |
β | Beta against Dow Jones | -0.28 | |
σ | Overall volatility | 2.17 | |
Ir | Information ratio | 0.18 |
EXACT Sciences Volatility Alert
EXACT Sciences exhibits very low volatility with skewness of 5.65 and kurtosis of 32.5. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure EXACT Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact EXACT Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.EXACT Sciences Fundamentals Vs Peers
Comparing EXACT Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze EXACT Sciences' direct or indirect competition across all of the common fundamentals between EXACT Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as EXACT Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of EXACT Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare EXACT Sciences to competition |
| Fundamentals | EXACT Sciences | Peer Average |
| Return On Equity | -0.0866 | -0.31 |
| Return On Asset | -0.0159 | -0.14 |
| Profit Margin | (0.06) % | (1.27) % |
| Operating Margin | (0.09) % | (5.51) % |
| Current Valuation | 21.13 B | 16.62 B |
| Shares Outstanding | 189.92 M | 571.82 M |
| Shares Owned By Insiders | 1.20 % | 10.09 % |
| Shares Owned By Institutions | 88.62 % | 39.21 % |
| Number Of Shares Shorted | 6.65 M | 4.71 M |
| Price To Earning | (38.17) X | 28.72 X |
| Price To Book | 7.84 X | 9.51 X |
| Price To Sales | 6.04 X | 11.42 X |
| Revenue | 3.25 B | 9.43 B |
| Gross Profit | 2.26 B | 27.38 B |
| EBITDA | 122.5 M | 3.9 B |
| Net Income | (207.95 M) | 570.98 M |
| Cash And Equivalents | 728.04 M | 2.7 B |
| Cash Per Share | 4.11 X | 5.01 X |
| Total Debt | 2.52 B | 5.32 B |
| Debt To Equity | 0.77 % | 48.70 % |
| Current Ratio | 2.48 X | 2.16 X |
| Book Value Per Share | 12.58 X | 1.93 K |
| Cash Flow From Operations | 491.44 M | 971.22 M |
| Short Ratio | 2.85 X | 4.00 X |
| Earnings Per Share | (5.35) X | 3.12 X |
| Price To Earnings To Growth | (1.07) X | 4.89 X |
| Target Price | 105.81 | |
| Number Of Employees | 7.1 K | 18.84 K |
| Beta | 1.42 | -0.15 |
| Market Capitalization | 19.61 B | 19.03 B |
| Total Asset | 5.86 B | 29.47 B |
| Retained Earnings | (4.71 B) | 9.33 B |
| Working Capital | 914.7 M | 1.48 B |
Note: Disposition of 14938 shares by Brian Baranick of EXACT Sciences at 101.59 subject to Rule 16b-3 [view details]
EXACT Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EXACT . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
EXACT Sciences Target Price Consensus
EXACT target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. EXACT Sciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 26 | Strong Buy |
Most EXACT analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand EXACT stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of EXACT Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationEXACT Sciences Target Price Projection
EXACT Sciences' current and average target prices are 103.31 and 105.81, respectively. The current price of EXACT Sciences is the price at which EXACT Sciences is currently trading. On the other hand, EXACT Sciences' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
EXACT Sciences Market Quote on 17th of February 2026
Target Price
Analyst Consensus On EXACT Sciences Target Price
EXACT Sciences Analyst Ratings
EXACT Sciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about EXACT Sciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of EXACT Sciences' financials, market performance, and future outlook by experienced professionals. EXACT Sciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
About EXACT Sciences Buy or Sell Advice
When is the right time to buy or sell EXACT Sciences? Buying financial instruments such as EXACT Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having EXACT Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.